Alexandre Moreau

Alexandre Moreau is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Country President for UCB in China since April 2022, Alexandre also contributes as an Advisory Board Member for DEFYMED SAS and co-founded AXXELIS AG, a consulting start-up in life sciences. Previously, Alexandre held significant leadership roles, including Vice President for UCB's Global Bone Patient Value Unit and Epilepsy Portfolio, Global Product Strategy Vice President at Roche Genentech, and Global Marketing Vice President at Sanofi. Academic credentials include a PharmD from the University of Biological & Pharmaceutical Sciences and advanced management degrees from INSEAD and Harvard Business School.